TREAT-NMD Executive Committee


Kevin Flanigan Kevin Flanigan - Chair of TREAT-NMD Executive Committee

Professor of Pediatrics and Neurology - Ohio State University College of Medicine

Dr. Kevin Flanigan is a Professor of Neurology and Pediatrics at the Ohio State University, and a Principal Investigator at the Center for Gene Therapy at Nationwide Children's Hospital in Columbus, Ohio. He has extensive experience in the design and development of patient registries, and has served as the Director of the United Dystrophinopathy Project, an NIH-funded genotype/phenotype database and registry.

More Info


Janbernd Kirschner Janbernd Kirschner

Consultant Pediatric Neurologist - University Medical Center Freiburg

Dr. Jan Kirschner is coordinator of the TREAT-NMD Clinical Trial Coordination Centre (CTCC) based in Freiburg, Germany. Jan has been joint coordinator of the German network for neuromuscular disorders MD-NET ( since 2008. He has been involved in planning and conducting several multicentre clinical trials. He was responsible for the coordination of a large multi-centre, placebo-controlled MD-NET trial in Duchenne muscular dystrophy. With the CTCC team in Freiburg Jan has established the Care and Trial Site Registry (CTSR) containing feasibility information about neuromuscular centres worldwide.

Call +4976127043750


Annemieke Aartsma-Rus Annemieke Aartsma-Rus

Professor - Leiden University Medical Center

Dr. Annemieke Aartsma-Rus played an important role in the development of the antisense mediated exon skipping therapy for Duchenne muscular dystrophy during her PhD research (2000-2004), which was supervised by Dr. Judith van Deutekom, Dr. Johan den Dunnen and Prof. Dr. Gert-Jan van Ommen at the Leiden University Medical Center, Department of Human Genetics (the Netherlands). She successfully defended her thesis titled “Development of an antisense-mediated exon skipping therapy for Duchenne Muscular Dystrophy – Making sense out of nonsense” on February 10th 2005. Since September 2004 she continued this research as a post doc under supervision of Dr. Judith van Deutekom.

More Info


Nathalie Goemans Nathalie Goemans

M.D - UZ Leuven

Nathalie Goemans, MD, PhD, is a paediatrician and child neurologist, with certification in rehabilitation medicine. She is head of clinic within the department of Pediatric Neurology and head of the Neuromuscular Reference Centre for Children at the University Hospitals Leuven. She has an academic position at the University of Leuven, Belgium. She is vice chair of the TGDOC within TREAT- NMD.

Nathalie has a particular interest in the multidisciplinary aspects and the dissemination of standards of care in neuromuscular disorders. Research activities involve therapy development and development of outcome measures to assess interventions in these diseases.

More Info

Call +32 16 34 38 45


Eric Hoffman Eric Hoffman

Director, Research Center for Genetic Medicine & The Wicker Project for Muscular Dystrophy Research - CINRG

Eric Hoffman, PhD earned his PhD in Genetics at Johns Hopkins University and then pursued post-doctoral training with Louis Kunkel at Boston Children’s Hospital working on Duchenne muscular dystrophy gene and protein identification.

More Info


Eugenio Mercuri Eugenio Mercuri

Professor of Pediatric Neurology - Università Cattolica del Sacro Cuore

Eugenio Mercuri Md PhD (Associate Professor in Pediatric Neurology): areas of expertise: congenital muscular dystrophy, outcome measures and assessment tools in neuromuscular disorders.


Yuriko Oda Yuriko Oda

President of Nonprofit-organization PADM - Patient association for distal myopathies

Yuriko was diagnosed with GNE Myopathy in 2002 and founded PADM, the Patients Association for Distal Myopathy in 2008. Japanese scientist Dr. Ichizo Nishino proved the effective material for GNE Myopathy, however there were no pharmaceutical companies interested in further development of a medicine. PADM repeatedly petitioned against this finally reversing this decision in Japan in 2010 followed by the US and other countries.

Since April 2008, PADM has been campaigning for distal myopathy to be recognised as a designated rare disease in Japan. After collecting over 2 million signatures they achieved their goal in 2015.

PADM wishes to overcome difficulties and disabilities not only for people with distal myopathies, but for all kinds of patients. They have recently started to build a new system for barrier-free map in 2015, when they received the grand prize in Google Impact Challenge in Japan.


Jes Rahbek Jes Rahbek

The Rehabilitation Centre for Neuromuscular Diseases

Jes is a specialist in neuromuscular rehabilitation and also a volunteer in Muskelsvindfonden, the Danish patient organization for NMD. Additionally Jes is Chairman of Muskelsvindfonden's 1) scientific committee, 2) ethical committee and 3) international relations committee.

He represents Muskelsvindfonden in the ENMC where he has just been elected Chairman of the Executive Committee.
Jes works as Chief Medical Officer and Director of the Danish National Rehabilitation Centre for Neuromuscular Diseases and is an associated partner in CARE-NMD which is a DMD project under TREAT-NMD.


Thomas Sejersen Thomas Sejersen

Associate Professor, Astrid Lindgrens Barnsjukhus - Karolinska Institute

Thomas Sejersen holds positions as Professor in Neuropediatrics at the Department of Women's and Children's Health of Karolinska Institute and consultant paediatrician at the Astrid Lindgrens Barnsjukhus (Stockholm, Sweden).


J. Andoni Urtizberea J. Andoni Urtizberea

Consultant, Hendaye / Head, Summer School of Myology, Paris - Hôpital Marin de Hendaye

Dr Jon Andoni Urtizberea is head of the internationally renowned Paris Summer School of Myology and a consultant at the neuromuscular reference centre at Hendaye Hospital in the French Basque region.